Annual General Meeting 2024

A3P Biomedical AB (publ) will hold the Annual General Meeting on May 15, 2024 at 14:00, at law firm Vinge, Smålandsgatan 20, 111 46, Stockholm.


Shareholders who wish to participate in the Annual General Meeting must (i) be recorded as a shareholder in the presentation of the share register prepared by Euroclear Sweden AB concerning the circumstances on 6 May 2024, and (ii) notify the Company of their intention to participate no later than 8 May 2024 by e-mail to or by mail to A3P Biomedical AB, “Annual General Meeting”, Kungsgatan 24, 111 35 Stockholm, Sweden. The notification shall include the shareholder’s name, personal identification number or corporate registration number, address, telephone number and the number of assistants, if any (not more than two) and, where applicable, information about proxies.

If a shareholder is represented by proxy, a written and dated power of attorney must be issued for the proxy. A proxy form is available on the Company’s website, If the power of attorney is issued by a legal entity, a certificate of registration or equivalent document of authority must be attached. To facilitate the registration at the general meeting, the power of attorney as well as the certificate of registration and other documents of authority should be sent to the Company at the address above so that it is received no later than 14 May 2024.


To be entitled to participate in the Annual General Meeting, a shareholder whose shares are registered in the name of a nominee must, in addition to giving notice of participation in the Annual General Meeting, register its shares in its own name so that the shareholder is listed in the share register kept by Euroclear Sweden AB as of 6 May 2024. Such registration may be temporary (so-called voting rights registration) and request for such voting rights registration shall be made to the nominee in accordance with the nominee’s procedures at such a time in advance as decided by the nominee. Voting right registrations that have been completed by the nominee no later than 8 May 2024 will be taken into account in the presentation of the share register.

Please note that all documentation provided will be in Swedish and that the meeting will be held in Swedish. For access to the documentation please follow this link:
Årsstämma 2024 – A3P Biomedical